Purchases and Sales Made in Q1 2024 in Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX) during Q1 2024. The information is specifically focused on institutions that hold shares of Gain Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
Dme Capital Management, LP
New York, NY |
BUY
|
- |
566KNew |
$1.82M - $2.85M
|
566K
$974K
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
248K+ 156189.31% |
$797K - $1.25M
|
249K
$427K
|
|
Apr 22, 2024
Q1 2024
|
Raymond James & Associates
St Petersburg, FL |
BUY
|
- |
236K+ 993.07% |
$758K - $1.19M
|
260K
$447K
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
48.3K+ 24.1% |
$155K - $243K
|
249K
$427K
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
BUY
|
- |
47.8K+ 173.07% |
$153K - $241K
|
75.4K
$130K
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
31.7K+ 247.98% |
$102K - $160K
|
44.4K
$76.4K
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
31K+ 35.05% |
$99.4K - $156K
|
119K
$205K
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
30.8KNew |
$99K - $155K
|
30.8K
$53K
|
|
May 13, 2024
Q1 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
25.6K+ 16.91% |
$82.2K - $129K
|
177K
$305K
|
|
Apr 25, 2024
Q1 2024
|
Simplex Trading, LLC
|
BUY
|
- |
18KNew |
$57.7K - $90.6K
|
18K
$30.9K
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
8.56K+ 24.82% |
$27.5K - $43.2K
|
43.1K
$74.1K
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
3.9K+ 9.11% |
$12.5K - $19.7K
|
46.7K
$80.3K
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3.38KNew |
$10.8K - $17K
|
3.38K
$5.81K
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
2.97K+ 6.83% |
$9.54K - $15K
|
46.5K
$80K
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
BUY
|
- |
684New |
$2.2K - $3.45K
|
684
$1.18K
|
|
May 14, 2024
Q1 2024
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
225New |
$722 - $1.13K
|
225
$387
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
29+ 0.78% |
$93.1 - $146
|
3.76K
$6.46K
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-260- 5.31% |
$835 - $1.31K
|
4.63K
$7.97K
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-500- 15.15% |
$1.61K - $2.52K
|
2.8K
$4.82K
|
|
May 10, 2024
Q1 2024
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-1.94K- 49.17% |
$6.21K - $9.76K
|
2K
$3.44K
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-5.35K- 38.15% |
$17.2K - $27K
|
8.67K
$14.9K
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-16.1K- 34.92% |
$51.7K - $81.1K
|
30K
$51.6K
|
|
May 15, 2024
Q1 2024
|
Prelude Capital Management, LLC
New York, NY |
SELL
|
- |
-22.3K- 38.35% |
$71.5K - $112K
|
35.8K
$61.6K
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-61.2K- 93.54% |
$196K - $308K
|
4.22K
$7.26K
|